Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy.
about
A balancing act: efflux/influx in mycobacterial drug resistanceDelafloxacin, a non-zwitterionic fluoroquinolone in Phase III of clinical development: evaluation of its pharmacology, pharmacokinetics, pharmacodynamics and clinical efficacyVibrio cholerae VexH encodes a multiple drug efflux pump that contributes to the production of cholera toxin and the toxin co-regulated pilusReduced Susceptibility to Rifampicin and Resistance to Multiple Antimicrobial Agents among Brucella abortus Isolates from Cattle in BrazilXenobiotic efflux in bacteria and fungi: a genomics updateTermite usage associated with antibiotic therapy: enhancement of aminoglycoside antibiotic activity by natural products of Nasutitermes corniger (Motschulsky 1855)A DHA14 drug efflux gene from Xanthomonas albilineans confers high-level albicidin antibiotic resistance in Escherichia coli.Herbal therapy associated with antibiotic therapy: potentiation of the antibiotic activity against methicillin--resistant Staphylococcus aureus by Turnera ulmifolia L.The Vibrio cholerae VexGH RND Efflux System Maintains Cellular Homeostasis by Effluxing Vibriobactin.Use of an efflux pump inhibitor to determine the prevalence of efflux pump-mediated fluoroquinolone resistance and multidrug resistance in Pseudomonas aeruginosa.Reciprocal regulation of resistance-nodulation-division efflux systems and the Cpx two-component system in Vibrio cholerae.Quinolones: from antibiotics to autoinducers.The ComP-ComA quorum system is essential for "Trojan horse" like pathogenesis in Bacillus nematocidaThe challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.Substrate-dependent activation of the Vibrio cholerae vexAB RND efflux system requires vexRGlobal gene expression profiling and antibiotic susceptibility after repeated exposure to the carbon monoxide-releasing molecule-2 (CORM-2) in multidrug-resistant ESBL-producing uropathogenic Escherichia coliCharacterization of the RND-type multidrug efflux pump MexAB-OprM of the plant pathogen Pseudomonas syringae.Antibiotic efflux pumps in Gram-negative bacteria: the inhibitor response strategy.Leishmania panamensis infection and antimonial drugs modulate expression of macrophage drug transporters and metabolizing enzymes: impact on intracellular parasite survival.Navigating tuberculosis drug discovery with target-based screening.Siderophore-dependent iron uptake systems as gates for antibiotic Trojan horse strategies against Pseudomonas aeruginosa.Renaissance of antibiotics against difficult infections: Focus on oritavancin and new ketolides and quinolones.Pseudomonas aeruginosa: arsenal of resistance mechanisms, decades of changing resistance profiles, and future antimicrobial therapies.Control of Multidrug-Resistant Gene Flow in the Environment Through Bacteriophage Intervention.RND efflux pump mediated antibiotic resistance in Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa: a major issue worldwide.The role of gyrA and parC mutations in fluoroquinolones-resistant Pseudomonas aeruginosa isolates from Iran.Cooperation between prokaryotic (Lde) and eukaryotic (MRP) efflux transporters in J774 macrophages infected with Listeria monocytogenes: studies with ciprofloxacin and moxifloxacin.Can microbial cells develop resistance to oxidative stress in antimicrobial photodynamic inactivation?Gallic acid-based indanone derivative interacts synergistically with tetracycline by inhibiting efflux pump in multidrug resistant E. coli.Effects of efflux transporter genes on susceptibility of Escherichia coli to tigecycline (GAR-936).Natural products from the termite Nasutitermes corniger lowers aminoglycoside minimum inhibitory concentrations.ATP-dependent motor activity of the transcription termination factor Rho from Mycobacterium tuberculosis.Vibrio cholerae RND family efflux systems are required for antimicrobial resistance, optimal virulence factor production, and colonization of the infant mouse small intestine.A variation of the translation attenuation model can explain the inducible regulation of the pBC16 tetracycline resistance gene in Bacillus subtilis.The streptomycin-sulfadiazine-tetracycline antimicrobial resistance element of calf-adapted Escherichia coli is widely distributed among isolates from Washington state cattleInhibition of bacterial multidrug resistance by celecoxib, a cyclooxygenase-2 inhibitor.A Novel indole compound that inhibits Pseudomonas aeruginosa growth by targeting MreB is a substrate for MexAB-OprMSynthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus.Role of efflux pumps and topoisomerase mutations in fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.Bacteria isolated from sewage influent resistant to ciprofloxacin, chloramphenicol and tetracycline.
P2860
Q24644870-36790906-91D2-4838-BCBF-D9FCB7661659Q26824268-B3570065-583C-4A38-9014-C9F539FDB7F9Q28483996-2B90840A-4897-412B-935A-481F024CE975Q28546606-2F1AFC9D-F029-4406-ACF7-F6561D6D23B4Q28834633-CE007A3C-42B3-4AF1-8649-9F38C30D8A22Q30873874-004B146B-DA1B-41FF-A8C5-BB70CA422EDDQ33249809-B7763527-AB8A-4CF6-BDA9-8599FEEE165AQ33441842-5BDBFD38-EFDB-4A46-A5E8-26D4B18CE730Q33691851-068C25D7-4889-45D1-903E-7906184AF1B9Q33806021-18729CFE-2F2A-4D22-9236-8475CD30C3EEQ33899779-6C2CDDC2-8FD2-4582-B468-BC69F0CD74E2Q34133116-A37EB925-E092-4443-934D-AE665C56889FQ35018632-D4F80BD8-D871-4A44-B3B5-243924CB069BQ35482558-3938A94C-DEFD-43E4-A166-A67FA02FD396Q35564002-CA37714E-1FE7-4604-9529-068822209D95Q36394954-32E7E4BD-B8BC-450D-84EB-D5B59DF37495Q36710544-110FE52E-19AB-4D19-83DB-2C03399FC014Q36710571-546A9064-8E4F-45CD-9079-E30C71C6E382Q37388291-A28F9AD2-64C2-4AD9-A57B-50247510AAA0Q38014956-C30E196C-69A3-4A4E-B7FE-E2649F1BF8A0Q38183671-85B96AC4-481D-4041-BA6D-706A9C354919Q38233471-B1E48080-3D4E-4A27-9D1C-EC0AE5AF79C1Q38599969-A6473859-66FD-4223-99A2-E8464D6B7149Q38976992-849C5B61-AA4E-4BC8-B884-91584A3052C8Q39065336-2E8D0081-1FFB-4294-9D94-A38B6241266CQ39310402-6900733A-7B05-4D24-A596-707F6F9D3DFDQ39968960-FC3BDE87-5E1E-4284-B5E1-F22E6EEC4F3AQ40069067-834FC2F1-8244-46F4-BBB9-8F7B6653D423Q40874282-58FB814B-0C9F-4D45-808F-C7DE4C6A5FE0Q40882661-BED447AA-50D3-4CE2-9B2D-3B00C74D3857Q40912403-4C23C4BE-FA7A-4A44-AAB5-9A89B472B954Q41128165-6BAE9475-4B9D-4985-A2C3-AE43EC2BBB0FQ41342972-A42228A3-746C-4024-84A0-2280F8B81619Q41669317-6C08D949-3B88-445E-8251-893172C4822EQ41863022-069D48E6-5D24-4F1E-97E5-31D49305ABC6Q41970348-B1D1AA6A-35CF-424F-A2D8-B06F590BA940Q42637266-118A2F0E-F0A5-4E20-B09C-2F51FBB17BE9Q42948655-0755BF03-15EF-4FAF-BA11-0C63A0005107Q42949281-69D6BE70-9D3D-47CD-8867-6B7DAD79795DQ46175351-58A02345-B594-4EE6-802D-C76A9DEE5F97
P2860
Antibiotic efflux pumps in prokaryotic cells: occurrence, impact on resistance and strategies for the future of antimicrobial therapy.
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Antibiotic efflux pumps in pro ...... ture of antimicrobial therapy.
@ast
Antibiotic efflux pumps in pro ...... ture of antimicrobial therapy.
@en
type
label
Antibiotic efflux pumps in pro ...... ture of antimicrobial therapy.
@ast
Antibiotic efflux pumps in pro ...... ture of antimicrobial therapy.
@en
prefLabel
Antibiotic efflux pumps in pro ...... ture of antimicrobial therapy.
@ast
Antibiotic efflux pumps in pro ...... ture of antimicrobial therapy.
@en
P2093
P356
P1476
Antibiotic efflux pumps in pro ...... ture of antimicrobial therapy.
@en
P2093
Glupczynski Y
Pechère JC
Tulkens PM
Van Bambeke F
P304
P356
10.1093/JAC/DKG224
P407
P577
2003-04-14T00:00:00Z